Your browser doesn't support javascript.
loading
Termoestabilidade da vacina contra a raiva, tipo Fuenzalida & Palacios, uso humano / Thermostability of rabies vaccine, type Fuenzalida & Palacios, for human use
Albas, Avelino; Fuches, Regina Maria Mourao; Gallina, Neuza Maria Frazatti; Mendonça, Rita Maria Zucatelli; Fang, Francisco Liauw; Valentini, Elizabeth Juliana Ghiuro.
Afiliação
  • Albas, Avelino; Instituto Butantan. Seção de Vírus Neurotrópicos. São Paulo. BR
  • Fuches, Regina Maria Mourao; Instituto Butantan. Seção de Vírus Neurotrópicos. São Paulo. BR
  • Gallina, Neuza Maria Frazatti; Instituto Butantan. Seção de Vírus Neurotrópicos. São Paulo. BR
  • Mendonça, Rita Maria Zucatelli; Instituto Butantan. Seção de Vírus Neurotrópicos. São Paulo. BR
  • Fang, Francisco Liauw; Instituto Butantan. Unidade de Producao de Vacina Contra o Sarampo. Sao Paulo. BR
  • Valentini, Elizabeth Juliana Ghiuro; Instituto Butantan. Seção de Vírus Neurotrópicos. São Paulo. BR
Rev. Inst. Med. Trop. Säo Paulo ; Rev. Inst. Med. Trop. Säo Paulo;34(1): 27-31, Jan.-Feb. 1992.
Article em Pt | LILACS | ID: lil-320634
Biblioteca responsável: BR1.1
RESUMO
Ten lots of Fuenzalida & Palacios type antirabies vaccine for human use, produced at the Instituto Butantan (São Paulo, Brazil) were stored at temperatures of 45, 37, 28 and 2-8 degrees C. The potency of each lot was determined in samples taken at varied time intervals using the NIH method and lots presenting antigenic values > or = 0,3 were considered satisfactory for use. After 2 hours at 45 degrees C the antigenic value of one out of 10 lots tested was found to be less than the minimum required value. At 37 degrees C all lots maintained satisfactory antigenic values until the third day of storage, whilst at 28 and 2-8 degrees C the potency was fully maintained, respectively for 10 and 360 days. At the ideal temperature of 2-8 degrees C, 100 of the tested vaccines maintained the minimum required antigenicity for a longer period (16 months) than the expiration time of 6-12 months usually recommended for this type of biological produced in Latin American and Caribbean countries. Thus, the obtained data suggested that in countries still producing Fuenzalida & Palacios type vaccine, the expiration tim could be extended to 16 months, what could prevent the unnecessary discarding of products still in useful condition.
Assuntos
Texto completo: 1 Base de dados: LILACS Assunto principal: Vacina Antirrábica Idioma: Pt Ano de publicação: 1992 Tipo de documento: Article País de afiliação: Brasil
Texto completo: 1 Base de dados: LILACS Assunto principal: Vacina Antirrábica Idioma: Pt Ano de publicação: 1992 Tipo de documento: Article País de afiliação: Brasil